Introducing the Cancer Report: Sharing Research and Developments

Photo of the Penn State Cancer Institute building entrance.On behalf of the physicians and faculty at the Penn State Cancer Institute, I’m pleased to present the inaugural issue of the Cancer Report, a new publication developed to share innovative treatment solutions and advanced research, and to highlight how they work together to enhance the care of individuals with cancer. I envision the Cancer Report as a way for our clinicians and scientists to share research findings, ongoing trials, developments in biomedical engineering and new collaborations between Penn State Cancer Institute and many of our peers in the field.

Penn State Cancer Institute strives to advance the study of cancer by utilizing the many resources afforded by the clinical and research faculty at Penn State Health Milton S. Hershey Medical Center and the Pennsylvania State University. We treat more than 2,000 individual cases each year, including a large, underserved rural population.

Each day, innovative technologies are applied to treatment options and decisions for individuals with cancer, with special emphasis on the precise delivery of radiation therapy. In addition, biomedical engineering and material sciences have given rise to our strong nanotechnology program, pioneering novel methods of drug delivery. As treatment modalities improve, we are at the forefront of academic medical centers. We are developing a rapidly growing survivorship program, which offers an integrated approach to cancer education, prevention, screening, diagnosis, treatment and follow-up care.

Our team is committed to advancing the field in improved bench-to-bedside treatments. With access to the many resources available through Penn State, we have more than 150 investigators from more than 20 University departments researching experimental therapeutics, mechanisms of carcinogenesis and cancer control. The strength and potential of this cross-collaboration includes the following relevant research examples: the University’s outstanding kinesiology and nutrition departments are part of our ongoing study of patients with colon cancer who have undergone initial resection; evaluation of the effect of a strictly-monitored exercise program on chemotherapy for these patients. Another first-of-its-kind research effort is our investigation of immune system modulation, specifically T cell exhaustion, and how it affects cancer recurrence in hematologic cancers.

To further expand and deepen our dedication to research, Penn State Cancer Institute is part of the Big Ten Cancer Research Consortium, which conducts hypothesis-driven, highly translational oncology trials that leverage the scientific and clinical expertise of Big Ten universities, as well as partnerships with the California Cancer Consortium and the National Cooperative Clinical Trial group.

In addition to trials conducted in partnership with the Big Ten Cancer Research Consortium, we are currently conducting more than 120 trials in various types of adult and pediatric cancers.

Our goal is to make the Cancer Report one of many ways to create a dialog with like-minded specialists about the latest approaches to meeting the challenges faced by oncologic subspecialties. I look forward to sharing more with you as we continue to enhance and advance care patients with cancer.

Sincerely,
Raymond Hohl, MD, PhD
Director, Penn State Cancer Institute


Photo of Raymond Hohl, MD, PhDRaymond Hohl, MD, PhD
Director, Penn State Cancer Institute
PHONE: 717-531-4034
E-MAIL: rhohl@hmc.psu.edu
FELLOWSHIP: Hematology/oncology, University of Chicago Medical Center, Chicago, Ill.
RESIDENCY: Internal medicine, University of Chicago Medical Center, Chicago, Ill.
MEDICAL SCHOOL: Rush University, Chicago, Ill.

 


If you would like to refer a patient to the Cancer Institute, please see our Referring Physicians page.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s